Alkermes (Ireland)

Recent papers from Alkermes (Ireland)

1. Improvement in Patient-reported Disease Severity, Cognitive Functioning, and Fatigue in Patients With Narcolepsy Type One Treated With Alixorexton, an Orexin Two Receptor Agonist, in the Vibrance-1 Phase Two Study (P6-14.002)Neurology · 2026
2. Breastfeeding and Subsequent Neuropsychological Outcomes at Age 6-Years-Old in the MONEAD Study (LS2.009)Neurology · 2026
3. 0743 Vibrance-2: A Randomized Phase 2 Study Evaluating Efficacy and Safety of the Orexin 2 Receptor Agonist Alixorexton in Patients with Narcolepsy Type 2SLEEP · 2026
4. 0698 Real-World Experience and Impact of Cognitive Impairment in Narcolepsy and Idiopathic Hypersomnia: Survey Results from the ASPIRE StudySLEEP · 2026
5. 0699 Real-World Experience and Impact of Fatigue in Narcolepsy and Idiopathic Hypersomnia: Survey Results from the ASPIRE StudySLEEP · 2026
6. 0724 Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton in Patients with Narcolepsy Type 1: The Phase 2 Vibrance-1 StudySLEEP · 2026
7. 0729 Improvements in Quality of Life in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist AlixorextonSLEEP · 2026
8. 0747 Alixorexton Improved Patient-Reported Disease Severity, Cognitive Functioning, and Fatigue in Patients with Narcolepsy Type 1 in the Vibrance-1 StudySLEEP · 2026
9. Outcomes in pediatric recipients of ABO-incompatible liver transplants: An analysis of the SPLIT registry.2026
10. Flexible bronchoscopy in the intensive care unit: the FLEXICARE surveyERJ Open Research · 2025
11. Strategies for Managing the COVID-19 Pandemic and Lessons Learnt: An Irish PerspectivePublic health reviews · 2025
12. Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of SchizophreniaNeuropsychiatric Disease and Treatment · 2025
13. Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based studyThe Lancet Regional Health - Europe · 2024
14. Biomechanical Effects of Titanium Alloy Based Single versus Dual Cage Fusion Devices2024
15. Using qualitative exit interviews to explore schizophrenia burden and treatment experience in clinical trial patientsFrontiers in Psychiatry · 2024
16. Perspectives on current approaches to virtual screening in drug discoveryExpert Opinion on Drug Discovery · 2024
17. 23 Applied occupational hygiene in pharmaceutical industriesAnnals of Work Exposures and Health · 2024
18. 0673 The Burden of Living with Narcolepsy : Patient Perspectives from In-Depth Qualitative InterviewsSLEEP · 2024
19. Ten years of the manufacturing classification system: a review of literature applications and an extension of the framework to continuous manufacturePharmaceutical Development and Technology · 2024
20. Verbal Abilities at Age 6-years-old of Children of Women with vs. Without Epilepsy in the MONEAD Study (S19.007)Neurology · 2024